QuidelOrtho Corporation, a global leader in in vitro diagnostics, has received FDA 510(k) clearance for its VITROS hs Troponin I Reagent Pack, known as the
QuidelOrtho, a major player in point-of-care diagnostic testing, is introducing the QuickVue Influenza + SARS Test to its range of products. This quick test is
QuidelOrtho Corporation, a major player in in vitro diagnostics, has announced the appointment of Erich Wolff as Executive Vice President of Strategy and Corporate Development.
QuidelOrtho Corporation has launched its Certified Analyzer Program, a new effort to make reliable diagnostic testing more accessible in rural and community hospitals across the
New executives bring deep expertise to elevate quality and accelerate innovation across global operations QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies
Company Intends to Acquire LEX Diagnostics Upon U.S. FDA Clearance QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings,
QuidelOrtho Corporation announces the availability of the QuidelOrtho Results Manager System, an informatics solution designed to address the growing demands of modern laboratories. The Results
